“The good physician treats the disease; the great physician treats the patient who has the disease.”
– William Osler

We are proud to share highlights from our successful Two-Day Pleuroscopy Camp—an important step forward in our mission to advance lung health and respiratory care.

The camp brought together a team of skilled specialists dedicated to providing life-changing interventions for patients with pleural diseases. Through minimally invasive pleuroscopy procedures, we improved diagnostic accuracy and provided timely treatment for conditions such as unexplained pleural effusions and malignancies.

Over the course of the two days, our expert teams worked with dedication to ensure each patient received personalized, high-quality care. Beyond the procedures themselves, the camp represented a broader commitment to early detection, better patient outcomes, and strengthening healthcare capacity in the fight against respiratory diseases.

We extend our deepest gratitude to our dedicated medical professionals, our support teams, and the patients who entrusted us with their care. 

AstraZeneca | Kenyatta National Hospital. | Respiratory Society of Kenya | Johns Hopkins Hospital | Jacqueline Wanjiku Kagima MD, PhD | Christine Argento | Victoria Gonzalez | Andrew Owuor | Joan Kagema | Kevin Kiptoo | Joseph Mutie .Your commitment and collaboration made this initiative a success.

Together, we are building a healthier future—one breath at a time.

One of the core outputs of the LIGHT consortium is capacity strengthening for individuals, institutions and multi-stakeholder networks in countries to produce, adapt, translate and use evidence, and manage research. In line with this, LIGHT   partners in Kenya, AFIDEP and Respiratory Society of Kenya (ReSoK) are facilitating a scientific manuscript writing workshop in Naivasha, Kenya from 14–18 July 2025. Hosted by ReSoK, the workshop includes participants from the Ministry of Health’s Division of National Tuberculosis, Leprosy and Lung Disease Program (NTLD-P), County Government representatives, and key partners in lung health in Kenya including Amref Health Africa, Centre for Health Solutions – Kenya, Clinton Health Access Initiative, Kenya Medical Research Institute and  Population Services Kenya.

The workshop was officially opened by Aiban Ronoh, Head Monitoring and Evaluation and Research at NTLD-P on behalf of  , the Head of NTLD-P program. He highlighted that research is an important focus area and shared the NTLD-P’s vision of developing a national, inclusive, and demand-driven tuberculosis (TB) research agenda.

Intensified research and innovation is the third pillar of the END TB Strategy and LIGHT strives to support the documentation of research, as well as bridging the evidence policy gaps through evidence informed decision making. We look forward to a busy but fulfilling week as we advance TB Research Capacity in Kenya!

As part of streamlining the implementation and dissemination of TB and Lung Health research in Kenya, NTLD-P spearheaded the formation of TB and Lung Health research taskforce in January 2025 where LIGHT partners (ReSoK and AFIDEP) are committee members.

Prof. Jeremiah Chakaya, ReSoK’s Chief Executive Officer and Programme Team Lead at LIGHT Consortium gave an overview of LIGHT`s research focus on gender and tuberculosis (TB). With men and adolescents/young adults having a higher burden of TB, and higher rates of undesirable treatment outcomes, age and gender-responsive TB prevention and care policies and strategies are required to accelerate ending TB.  Prof. Chakaya further stressed on the importance of scientific research and the purpose it serves in advancing science and translation of policy and practice.

LIGHT Consortium`s Dr Beate Ringwald virtually conducted a sensitisation on publishing qualitative research findings. It was an interactive session with questions, for example, “How many quotes are considered too much?,” reflexivity, trustworthiness of research data, and highlights of common mistakes in documentation of qualitative research.

Intensified research and innovation is the third pillar of the END TB Strategy and LIGHT strives to support the documentation of research, as well as bridging the evidence policy gaps through evidence informed decision making. We look forward to a busy but fulfilling week as we advance TB Research Capacity in Kenya!

The LIGHT Consortium aims to contribute to real-world change and leave no-one affected by TB in sub-Saharan Africa behind!